These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20348231)

  • 1. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.
    North CM; Crawford RB; Lu H; Kaminski NE
    Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
    Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
    Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
    Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
    J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
    Sulentic CE; Holsapple MP; Kaminski NE
    Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
    Phadnis-Moghe AS; Crawford RB; Kaminski NE
    Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells.
    Crawford RB; Sulentic CE; Yoo BS; Kaminski NE
    Toxicol Sci; 2003 Oct; 75(2):333-42. PubMed ID: 12883080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
    Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
    Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells.
    Lu H; Crawford RB; Kaplan BL; Kaminski NE
    Toxicol Appl Pharmacol; 2011 Sep; 255(3):251-60. PubMed ID: 21807014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AhR and NF-κB/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region.
    Salisbury RL; Sulentic CE
    Toxicol Sci; 2015 Dec; 148(2):443-59. PubMed ID: 26377645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells.
    Yoo BS; Boverhof DR; Shnaider D; Crawford RB; Zacharewski TR; Kaminski NE
    Toxicol Sci; 2004 Feb; 77(2):272-9. PubMed ID: 14600275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity.
    Snyder NK; Kramer CM; Dooley RK; Holsapple MP
    Drug Chem Toxicol; 1993; 16(2):135-63. PubMed ID: 8486096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Bhattacharya S; Conolly RB; Kaminski NE; Thomas RS; Andersen ME; Zhang Q
    Toxicol Sci; 2010 May; 115(1):51-65. PubMed ID: 20123757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous in vivo time course and dose response evaluation for TCDD-induced impairment of the LPS-stimulated primary IgM response.
    North CM; Crawford RB; Lu H; Kaminski NE
    Toxicol Sci; 2009 Nov; 112(1):123-32. PubMed ID: 19675145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation.
    Luster MI; Germolec DR; Clark G; Wiegand G; Rosenthal GJ
    J Immunol; 1988 Feb; 140(3):928-35. PubMed ID: 3257509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation.
    De Abrew KN; Kaminski NE; Thomas RS
    Toxicol Sci; 2010 Dec; 118(2):454-69. PubMed ID: 20819909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Zhang Q; Kline DE; Bhattacharya S; Crawford RB; Conolly RB; Thomas RS; Andersen ME; Kaminski NE
    Toxicol Appl Pharmacol; 2013 Apr; 268(1):17-26. PubMed ID: 23357550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Karras JG; Holsapple MP
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):264-70. PubMed ID: 8171434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin attenuates capacity of hematopoietic stem cells to undergo lymphocyte differentiation.
    Ahrenhoerster LS; Tate ER; Lakatos PA; Wang X; Laiosa MD
    Toxicol Appl Pharmacol; 2014 Jun; 277(2):172-82. PubMed ID: 24709672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin.
    Zhang Q; Bhattacharya S; Kline DE; Crawford RB; Conolly RB; Thomas RS; Kaminski NE; Andersen ME
    BMC Syst Biol; 2010 Apr; 4():40. PubMed ID: 20359356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.
    Karras JG; Morris DL; Matulka RA; Kramer CM; Holsapple MP
    Toxicol Appl Pharmacol; 1996 Apr; 137(2):275-84. PubMed ID: 8661353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.